Ph.D. Raymond C. Stevens - CHIEF EXECUTIVE OFFICER, Director at Structure Therapeutics Inc.

Issuer-level insider activity

Role: CHIEF EXECUTIVE OFFICER, Director
Issuer ticker: GPCR on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Ph.D. Raymond C. Stevens since 23 Aug 2025

Reported holdings for Ph.D. Raymond C. Stevens in Structure Therapeutics Inc.

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Structure Therapeutics Inc.

Security class: Ordinary Shares
Shares / value: 1,554,586
Estimated value: $113,811,241
Report date: 19 Mar 2026
Price: $73.21
Ownership: Indirect

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Structure Therapeutics Inc.

Security class: Ordinary Shares
Shares / value: 1,401,593
Estimated value: $102,610,623
Report date: 19 Mar 2026
Price: $73.21
Ownership: Direct

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Structure Therapeutics Inc.

Security class: American Depositary Shares
Shares / value: 4,000
Estimated value: $878,520
Report date: 03 Mar 2026
Price: $219.63
Ownership: Indirect
Underlying class: Ordinary Shares
Underlying amount: 12,000

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Structure Therapeutics Inc.

Security class: American Depositary Shares
Shares / value: 1,824
Estimated value: $400,605
Report date: 20 Nov 2025
Price: $219.63
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 5,472

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Structure Therapeutics Inc.

Security class: Employee Stock Option (right to buy)
Shares / value: 322,230
Estimated value
Report date: 19 Mar 2026
Price
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount

Transaction history for Ph.D. Raymond C. Stevens in Structure Therapeutics Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .